Harbor Capital Advisors Inc. Has $4.97 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Harbor Capital Advisors Inc. cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 142,056 shares of the company's stock after selling 71,099 shares during the quarter. Harbor Capital Advisors Inc. owned 0.09% of Option Care Health worth $4,965,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health during the fourth quarter valued at approximately $26,000. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC boosted its position in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its stake in shares of Option Care Health by 434.8% during the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock worth $67,000 after purchasing an additional 1,561 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.27 on Friday, hitting $31.60. The company had a trading volume of 1,119,035 shares, compared to its average volume of 1,870,572. The firm has a 50 day moving average of $32.22 and a two-hundred day moving average of $30.26. The stock has a market capitalization of $5.17 billion, a price-to-earnings ratio of 26.55, a PEG ratio of 2.30 and a beta of 0.74. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the business earned $0.26 EPS. On average, research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.